Our established process and capabilities managing medicinal product safety expands from the developmental stage to continue throughout the post-marketing stage. Our model encompasses robust processes and a global presence including a strong legacy throughout the Asia-Pacific region, so clients can better manage costs by outsourcing clinical trial safety and pharmacovigilance to partner who understands the safety profile, costs and qualities of your product. Clients can expect a focus on quality and efficiency as required throughout a product lifecycle.
George Clinical’s safety and pharmacovigilance experts ensure a patient’s well-being is paramount. Striking the right balance between benefit and risk, we can provide safety surveillance strategies for the sustenance of the medicinal product throughout the product lifecycle.
George Clinical offers end-to-end oversight of all key safety aspects of product lifecycle.
The George Clinical PV team leverages Oracle Argus, a comprehensive, highly scalable safety database for case management and reporting activities. This advanced platform not only consolidates a client’s clinical trial safety data into a single system, it eases integration with other toolsets your organization already relies upon. Machine learning and rules-based process automation greatly improve the speed of data processing, lower monitoring costs and reduce manual input and the risk of poor data integrity.
As many developing nations are actively upgrading and implementing more stringent regulation for local safety monitoring, George Clinical helps clients to meet the mandatory requirement of a local presence via a qualified person with regional language proficiency by reducing operation cost with a balanced centralized and decentralized model. Our PV team includes local experts in China, Malaysia, Taiwan, Hong Kong, Indonesia, Philippines, India, South Korea, Australia, Singapore and elsewhere.
George Clinical has grown rapidly across the Asia-Pacific region and continues to develop and enhance operations around the globe. Headquartered in Sydney, Australia, George Clinical has operational hubs in China, India, Hong Kong, South Korea, Taiwan, Malaysia, Philippines, Japan, Singapore, New Zealand, United Kingdom, Czech Republic and the United States of America.